Untitled
Untitled
CVC-controlled Recordati buys UK start-up to expand rare cancers portfolio | Financial Times
Untitled
Медицинские препараты Recordati Ilac Стамбул, Турция
Recordati Company Profile: Stock Performance & Earnings | PitchBook
Recordati acquires AstraZeneca blood pressure brands - PMLiVE
A European Specialty Pharmaceutical Group
RECORDATI FINALIZES ITS ACQUISITION OF FRIK İLAÇ IN TURKEY
Медицинские препараты Recordati Ilac Стамбул, Турция
PATIENTS | PEOPLE | PRODUCTS | PERFORMANCE
NEWS RELEASE
Медицинские препараты Recordati Ilac Стамбул, Турция
RECORDATI: BOARD APPROVES THE 2011 ACCOUNTS. REVENUE € 762.0 MILLION (+4.7%), OPERATING INCOME € 1
growth
economiaefinanza - Lettera all'investitore » Recordati, l'Ebitda 2011 è atteso al di sopra dei 190 milioni - Versione stampabile
PATIENTS | PEOPLE | PRODUCTS | PERFORMANCE
RECORDATİ SÜSPANSİYON HATTINA YATIRIM YAPTI
Recordati buys Turkey's Frik Ilac for $130 million - PharmaTimes
RECORDATI FINALIZES ITS ACQUISITION OF FRIK İLAÇ IN TURKEY
Untitled
RECORDATI: VERY GOOD FIRST HALF 2011 RESULTS. SALES +6.6%. NET INCOME +5.3%
Untitled
Медицинские препараты Recordati Ilac Стамбул, Турция
İş Girişim | Frik İlaç
Recordati S.p.A - About Us > History
